Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan's Acular available on U.K. market

June 14, 1996

Xalatan approved for U.S. market

June 14, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

Ofloxacin ophthalmic solution receives FDA approval

May 31, 1996

Carbonic anhydrase inhibitors from Alcon

May 31, 1996

Anti-VEGF oligonucleotides inhibit retinal neovascularization in preclinical model

May 17, 1996

SnET2 enters phase I/II for AMD indication

May 17, 1996

Pharmos, Bausch & Lomb expand Lotemax agreement

May 17, 1996

Dorzolamide approved for marketing in Canada

May 17, 1996

AI-300 effective in preliminary clinical study

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...